𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lymphocyte stimulation by autologous tumor cells in the presence of serum from the same patient or from healthy donors

✍ Scribed by F. Vánky; E. Klein; J. Stjernswärd; G. Trempe

Publisher
John Wiley and Sons
Year
1975
Tongue
French
Weight
756 KB
Volume
16
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Lymphocyte blastogenesis induced by autologous tumor biopsy cells, by allogeneic lymphocytes and by PHA, was performed in the presence of autologous or allogeneic serum collected from normal blood donors. In 13 of the 15 cases lymphocyte stimulation by autologous tumor cells was inhibited in the presence of autologous serum. In contrast, autologous serum somewhat enhanced the blastogenic effect of PHA and allogeneic lymphocytes.

📜 SIMILAR VOLUMES

Tumor-specific CD8+ T lymphocytes derive
Tumor-specific CD8+ T lymphocytes derived from the peripheral blood of prostate cancer patients by in vitro stimulation with autologous tumor cell lines
✍ Franck Housseau; Daniel A. Langer; Samuel D. Oberholtzer; Anitha Moorthy; Hyam I 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 150 KB 👁 2 views

## Abstract To identify tumor‐associated antigens as putative targets for developing immunotherapies against prostate cancer, we investigated the ability of T cells derived from the peripheral blood lymphocytes of prostate cancer patients to recognize autologous tumor cells. The technical challenge

Lymphocyte-mediated lysis of tumor cells
Lymphocyte-mediated lysis of tumor cells in vitro (ADCC), induced by serum antibodies from patients with urinary bladder carcinoma or from controls
✍ M. Troye; Y. Hansson; S. Paulie; P. Perlmann; H. Blomgren; B. Johansson 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 694 KB

## Abstract IgG fractions from serum of patients with transitional‐cell carcinoma of the urinary bladder (TCC), patients with carcinoma of the prostate (CC) and healthy donors (HD) were tested for their capacity to induce antibody‐dependent lymphocyte‐mediated cytotoxicity (ADCC) to tumor cells in